PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjThe BMJ
 
BMJ. 1995 June 3; 310(6992): 1433–1438.
PMCID: PMC2549813

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

Abstract

OBJECTIVE--To assess treatment discontinuation rates with selective serotonin reuptake inhibitors compared with tricyclic antidepressants. DESIGN--Meta-analysis of 62 randomised controlled trials. SUBJECTS--6029 patients with major unipolar depression. MAIN OUTCOME MEASURES--Pooled risk ratios for drop out rates with respect to all cases of discontinuation and those due to side effects and treatment failure. RESULTS--The total discontinuation rate was 10% lower with selective serotonin reuptake inhibitors than with tricyclic antidepressants (risk ratio 0.90; 95% confidence interval 0.84 to 0.97) and the drop out rate due to side effects was 25% lower (risk ratio 0.75; 0.66 to 0.84). There was no significant difference between drug classes in the drop out rates for treatment failure. The risk ratios for drop out did not differ significantly between individual selective serotonin reuptake inhibitors. CONCLUSIONS--Selective serotonin reuptake inhibitors are better tolerated than tricyclic antidepressants as measured by total numbers of drop outs. The definite advantage to selective serotonin reuptake inhibitors is explained by fewer drop outs due to side effects. The overall difference, however, is comparatively small and may not be clinically relevant. Analyses of cost effectiveness should not overestimate the advantage to selective serotonin reuptake inhibitors.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Harrison G. New or old antidepressants? New is better. BMJ. 1994 Nov 12;309(6964):1280–1281. [PMC free article] [PubMed]
  • Owens D. New or old antidepressants? Benefits of new drugs are exaggerated. BMJ. 1994 Nov 12;309(6964):1281–1282. [PMC free article] [PubMed]
  • Kasper S, Fuger J, Möller HJ. Comparative efficacy of antidepressants. Drugs. 1992;43 (Suppl 2):11–23. [PubMed]
  • Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ. 1993 Mar 13;306(6879):683–687. [PMC free article] [PubMed]
  • Jönsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry. 1994 May;164(5):665–673. [PubMed]
  • Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol. 1994 Spring;9(1):47–53. [PubMed]
  • Ballinger BR, Feely J. Antidepressants. Br Med J (Clin Res Ed) 1983 Jun 11;286(6381):1885–1887. [PMC free article] [PubMed]
  • Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995 Jan 28;310(6974):215–218. [PMC free article] [PubMed]
  • Debus JR, Rush AJ, Himmel C, Tyler D, Polatin P, Weissenburger J. Fluoxetine versus trazodone in the treatment of outpatients with major depression. J Clin Psychiatry. 1988 Nov;49(11):422–426. [PubMed]
  • de Jonghe F, Ravelli DP, Tuynman-Qua H. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression. Pharmacopsychiatry. 1991 Mar;24(2):62–67. [PubMed]
  • de Jonghe F, Swinkels J, Tuynman-Qua H. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression. Pharmacopsychiatry. 1991 Jan;24(1):21–27. [PubMed]
  • Dorman T. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. Int Clin Psychopharmacol. 1992 Jun;6 (Suppl 4):53–58. [PubMed]
  • Falk WE, Rosenbaum JF, Otto MW, Zusky PM, Weilburg JB, Nixon RA. Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol. 1989 Oct-Dec;2(4):208–214. [PubMed]
  • Feighner JP, Boyer WF, Meredith CH, Hendrickson GG. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. Int Clin Psychopharmacol. 1989 Jul;4(3):239–244. [PubMed]
  • Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG. Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry. 1991 Aug;52(8):329–335. [PubMed]
  • Ferreri M. Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):97–101. [PubMed]
  • Laakmann G, Blaschke D, Engel R, Schwarz A. Fluoxetine vs amitriptyline in the treatment of depressed out-patients. Br J Psychiatry Suppl. 1988 Sep;(3):64–68. [PubMed]
  • Mertens C, Pintens H. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin. Acta Psychiatr Scand. 1988 Jun;77(6):683–688. [PubMed]
  • Muijen M, Roy D, Silverstone T, Mehmet A, Christie M. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatr Scand. 1988 Sep;78(3):384–390. [PubMed]
  • Perez A, Ashford JJ. A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness. Curr Med Res Opin. 1990;12(4):234–241. [PubMed]
  • Perry PJ, Garvey MJ, Kelly MW, Cook BL, Dunner FJ, Winokur G. A comparative trial of fluoxetine versus trazodone in outpatients with major depression. J Clin Psychiatry. 1989 Aug;50(8):290–294. [PubMed]
  • Phanjoo AL, Wonnacott S, Hodgson A. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatr Scand. 1991 Jun;83(6):476–479. [PubMed]
  • Poelinger W, Haber H. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):47–50. [PubMed]
  • Taneri Z, Köhler R. Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):57–61. [PubMed]
  • Johnson DA. Depression: treatment compliance in general practice. Acta Psychiatr Scand Suppl. 1981;290:447–453. [PubMed]
  • Coleman BS, Block BA. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):475–478. [PubMed]
  • Ayuso-Gutiérrez JL, Ramos-Brieva JA. The course of manic-depressive illness. A comparative study of bipolar I and bipolar II patients. J Affect Disord. 1982 Mar;4(1):9–14. [PubMed]
  • Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. J Clin Psychiatry. 1985 Mar;46(3):84–87. [PubMed]
  • Gasperini M, Gatti F, Bellini L, Anniverno R, Smeraldi E. Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine. A double-blind study in depressed inpatients. Neuropsychobiology. 1992;26(4):186–192. [PubMed]
  • Gonella G, Baignoli G, Ecari U. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curr Med Res Opin. 1990;12(3):177–184. [PubMed]
  • Klok CJ, Brouwer GJ, van Praag HM, Doogan D. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand. 1981 Jul;64(1):1–11. [PubMed]
  • Lapierre YD, Browne M, Horn E, Oyewumi LK, Sarantidis D, Roberts N, Badoe K, Tessier P. Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry. 1987 Feb;48(2):65–68. [PubMed]
  • Lydiard RB, Laird LK, Morton WA, Jr, Steele TE, Kellner C, Laraia MT, Ballenger JC. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacol Bull. 1989;25(1):68–70. [PubMed]
  • March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. J Clin Psychiatry. 1990 May;51(5):200–202. [PubMed]
  • Mullin JM, Pandita-Gunawardena VR, Whitehead AM. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br J Clin Pract. 1988 Feb;42(2):51–55. [PubMed]
  • Nathan RS, Perel JM, Pollock BG, Kupfer DJ. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. J Clin Psychiatry. 1990 Sep;51(9):367–372. [PubMed]
  • Norton KR, Sireling LI, Bhat AV, Rao B, Paykel ES. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Disord. 1984 Dec;7(3-4):297–308. [PubMed]
  • Rahman MK, Akhtar MJ, Savla NC, Sharma RR, Kellett JM, Ashford JJ. A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pract. 1991 Winter;45(4):255–258. [PubMed]
  • Roth D, Mattes J, Sheehan KH, Sheehan DV. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(6):929–939. [PubMed]
  • Altamura AC, Percudani M, Guercetti G, Invernizzi G. Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):103–106. [PubMed]
  • Bremner JD. Fluoxetine in depressed patients: a comparison with imipramine. J Clin Psychiatry. 1984 Oct;45(10):414–419. [PubMed]
  • Bressa GM, Brugnoli R, Pancheri P. A double-blind study of fluoxetine and imipramine in major depression. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):69–73. [PubMed]
  • Chouinard G. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiatry. 1985 Mar;46(3 Pt 2):32–37. [PubMed]
  • Cohn JB, Wilcox C. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. J Clin Psychiatry. 1985 Mar;46(3 Pt 2):26–31. [PubMed]
  • Corne SJ, Hall JR. A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice. Int Clin Psychopharmacol. 1989 Jul;4(3):245–254. [PubMed]
  • Fabre LF, Scharf MB, Itil TM. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study. J Clin Psychiatry. 1991 Jun;52 (Suppl):62–67. [PubMed]
  • Feighner JP. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. J Clin Psychiatry. 1985 Sep;46(9):369–372. [PubMed]
  • Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry. 1985 Mar;46(3 Pt 2):20–25. [PubMed]
  • Feighner JP, Boyer WF, Merideth CH, Hendrickson GG. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression. Int Clin Psychopharmacol. 1989 Apr;4(2):127–134. [PubMed]
  • Judd FK, Moore K, Norman TR, Burrows GD, Gupta RK, Parker G. A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness. Aust N Z J Psychiatry. 1993 Mar;27(1):49–55. [PubMed]
  • Keegan D, Bowen RC, Blackshaw S, Saleh S, Dayal N, Remillard F, Shrikhande S, Cebrian Perez S, Boulton A. A comparison of fluoxetine and amitriptyline in the treatment of major depression. Int Clin Psychopharmacol. 1991 Summer;6(2):117–124. [PubMed]
  • Levine S, Deo R, Mahadevan K. A comparative trial of a new antidepressant, fluoxetine. Br J Psychiatry. 1987 May;150:653–655. [PubMed]
  • Nielsen BM, Behnke K, Arup P, Christiansen PE, Geisler A, Ipsen E, Maach-Møller B, Ohrberg SC. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder. Acta Psychiatr Scand. 1993 Apr;87(4):269–272. [PubMed]
  • Noyes R., Jr Suicide and panic disorder: a review. J Affect Disord. 1991 May-Jun;22(1-2):1–11. [PubMed]
  • Ropert R. Fluoxetine versus clomipramine in major depressive disorders. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):89–95. [PubMed]
  • Stark P, Hardison CD. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry. 1985 Mar;46(3 Pt 2):53–58. [PubMed]
  • Tamminen TT, Lehtinen VV. A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):51–56. [PubMed]
  • Young JP, Coleman A, Lader MH. A controlled comparison of fluoxetine and amitriptyline in depressed out-patients. Br J Psychiatry. 1987 Sep;151:337–340. [PubMed]
  • Bascara L. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients. Acta Psychiatr Scand Suppl. 1989;350:141–142. [PubMed]
  • Battegay R, Hager M, Rauchfleisch U. Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study). Neuropsychobiology. 1985;13(1-2):31–37. [PubMed]
  • Bignamini A, Rapisarda V. A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group. Int Clin Psychopharmacol. 1992 Jun;6 (Suppl 4):37–41. [PubMed]
  • Dunbar GC, Cohn JB, Fabre LF, Feighner JP, Fieve RR, Mendels J, Shrivastava RK. A comparison of paroxetine, imipramine and placebo in depressed out-patients. Br J Psychiatry. 1991 Sep;159:394–398. [PubMed]
  • Dunner DL, Cohn JB, Walshe T, 3rd, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC, Jr, et al. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry. 1992 Feb;53 (Suppl):57–60. [PubMed]
  • Guillibert E, Pelicier Y, Archambault JC, Chabannes JP, Clerc G, Desvilles M, Guibert M, Pagot R, Poisat JL, Thobie Y. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatr Scand Suppl. 1989;350:132–134. [PubMed]
  • Kuhs H, Rudolf GA. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline. Acta Psychiatr Scand Suppl. 1989;350:145–146. [PubMed]
  • Laursen AL, Mikkelsen PL, Rasmussen S, le Fèvre Honoré P. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline. Acta Psychiatr Scand. 1985 Mar;71(3):249–255. [PubMed]
  • Möller HJ, Berzewski H, Eckmann F, Gonzalves N, Kissling W, Knorr W, Ressler P, Rudolf GA, Steinmeyer EM, Magyar I, et al. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiatry. 1993 May;26(3):75–78. [PubMed]
  • Nielsen OA, Morsing I, Petersen JS, Larsen T, Møller SE, Manniche PM, Skausig OB. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta Psychiatr Scand. 1991 Sep;84(3):233–241. [PubMed]
  • Ohrberg S, Christiansen PE, Severin B, Calberg H, Nilakantan B, Borup A, Søgaard J, Larsen SB, Loldrup D, Bahr B, et al. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Acta Psychiatr Scand. 1992 Dec;86(6):437–444. [PubMed]
  • Cohn CK, Shrivastava R, Mendels J, Cohn JB, Fabre LF, Claghorn JL, Dessain EC, Itil TM, Lautin A. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry. 1990 Dec;51 (Suppl B):28–33. [PubMed]
  • Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, Masco HL, Mendels J. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry. 1990 Dec;51 (Suppl B):18–27. [PubMed]
  • Gravem A, Amthor KF, Astrup C, Elgen K, Gjessing LR, Gunby B, Pettersen RD, Kyrdalen L, Vaadal J, Ofsti E, et al. A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients. Acta Psychiatr Scand. 1987 May;75(5):478–486. [PubMed]
  • Byerley WF, Reimherr FW, Wood DR, Grosser BI. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression. J Clin Psychopharmacol. 1988 Apr;8(2):112–115. [PubMed]
  • Cohn JB, Crowder JE, Wilcox CS, Ryan PJ. A placebo- and imipramine-controlled study of paroxetine. Psychopharmacol Bull. 1990;26(2):185–189. [PubMed]
  • Feighner JP. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients. Int Clin Psychopharmacol. 1992 Jun;6 (Suppl 4):31–35. [PubMed]
  • Feighner JP, Boyer WF. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Acta Psychiatr Scand Suppl. 1989;350:125–129. [PubMed]
  • Feighner JP, Cohn JB, Fabre LF, Jr, Fieve RR, Mendels J, Shrivastava RK, Dunbar GC. A study comparing paroxetine placebo and imipramine in depressed patients. J Affect Disord. 1993 Jun;28(2):71–79. [PubMed]
  • Gagiano CA, Müller PG, Fourie J, Le Roux JF. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients. Acta Psychiatr Scand Suppl. 1989;350:130–131. [PubMed]
  • Guy W, Wilson WH, Ban TA, King DL, Manov G, Fjetland OK. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Psychopharmacol Bull. 1984 Winter;20(1):73–78. [PubMed]
  • Levine S, Deo R, Mahadevan K. A comparative trial of a new antidepressant, fluoxetine. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):41–45. [PubMed]
  • Loeb C, Albano C, Gandolfo C. Fluoxetine versus imipramine. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):75–79. [PubMed]
  • Manna V, Martucci N, Agnoli A. Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders. Int Clin Psychopharmacol. 1989 Jan;4 (Suppl 1):81–88. [PubMed]
  • Peselow ED, Filippi AM, Goodnick P, Barouche F, Fieve RR. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo. Psychopharmacol Bull. 1989;25(2):267–271. [PubMed]
  • Sinclair JC, Bracken MB. Clinically useful measures of effect in binary analyses of randomized trials. J Clin Epidemiol. 1994 Aug;47(8):881–889. [PubMed]
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. [PubMed]
  • Wilson A, Henry DA. Meta-analysis. Part 2: Assessing the quality of published meta-analyses. Med J Aust. 1992 Feb 3;156(3):173–187. [PubMed]
  • Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ. 1992 Nov 14;305(6863):1198–1202. [PMC free article] [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group